Summary: Florida House Bill 1617 introduces long-overdue regulation to stem cell and regenerative health clinics across the state. For trusted practices like STEMS Health, this legislation reinforces what is already standard: safe, ethical, science-based patient care. This article breaks down what the bill includes and what it means for current and future patients.
What Is House Bill 1617 and Why Was It Introduced?
Stem cell and regenerative medicine clinics have grown rapidly in Florida, attracting patients from across the country seeking advanced therapies for chronic pain, orthopedic issues, and age-related decline. But with that growth has come concern.
Too many providers have operated without oversight, marketing experimental treatments as cures, skipping informed consent, or failing to disclose risks. In response, Florida legislators introduced House Bill 1617 to create clear standards, improve patient safety, and eliminate unlicensed or deceptive providers.
This bill is not about limiting access—it’s about protecting patients from harm and holding clinics accountable.
Key Provisions of Florida House Bill 1617
Mandatory Registration of Clinics
Any clinic offering “regenerative health care services,” including stem cell therapies, must register with the Florida Department of Health. This ensures providers meet state standards and can be held accountable if patient safety is compromised.
Informed Consent Requirements
Providers must offer patients a written, signed consent form that discloses:
- The risks and benefits of the treatment
- Whether the therapy is FDA-approved or investigational
- Any alternative treatment options available
Advertising and Marketing Standards
The bill prohibits misleading advertising, especially claims that a treatment is “approved” or “proven” when it is still investigational. Providers must be honest about what their therapies can and cannot do.
State Oversight and Enforcement
The Florida Department of Health will have the authority to audit clinics, investigate complaints, issue cease-and-desist orders, and refer egregious violations to the medical board or law enforcement.
What the Bill Aims to Achieve
At its core, HB 1617 is about protecting patients and restoring trust. By defining what clinics can and cannot do, it empowers individuals to make informed decisions about their health. It also levels the playing field—holding all clinics to the same ethical and clinical standards.
Most importantly, it ensures that patients receive care that is transparent, traceable, and rooted in safety.
STEMS Health’s Position: We Already Go Beyond HB 1617
For Dr. Ankeet Choxi, Dr. Jarred Mait, and the entire team at STEMS Health, this legislation is welcome news. Why? Because the standards it introduces are already part of the clinic’s everyday practice.
Registered and Board-Certified Physicians: All care is delivered by licensed, trained medical professionals.
FDA-Compliant Therapies: Treatments offered at STEMS Health are based on scientific evidence and conducted within the boundaries of regulatory approval.
Transparent Patient Education: Every patient receives detailed information about their treatment—its goals, expected outcomes, and alternatives—well before anything is administered.
Ethical Marketing: You won’t find exaggerated claims or unsubstantiated promises here. STEMS Health builds trust by being transparent, and results-driven.
In fact, if HB 1617 becomes law, very little will change at STEMS Health—because the clinic is already doing what the bill seeks to enforce.
What This Means for Patients
If you’re already a patient at STEMS Health: You can rest easy knowing your care is already delivered according to the highest safety and transparency standards in Florida—even before the law requires it.
If you’re considering regenerative treatment for the first time, HB 1617 can serve as your checklist for choosing a clinic. Ask:
- Is the clinic registered with the state?
- Are the physicians licensed and experienced?
- Are treatments explained clearly and backed by science?
- When you walk into STEMS Health, the answer to all of those is a confident ‘yes’.
Safer Care Starts with Responsible Clinics
Florida House Bill 1617 is not a threat to regenerative medicine—it’s a safeguard for patients. Clinics that are already doing things the right way, like STEMS Health, are not only ready for this law—they’ve been ahead of it.
The future of regenerative health in Florida should be built on science, integrity, and transparency. That’s the foundation STEMS Health has stood on since day one.
FAQs – HB 1617 Stem Cell Therapy Treatment in Florida
Does Florida House Bill 1617 ban stem cell treatments?
No. The bill does not ban stem cell therapy. Instead, it regulates how these treatments are offered, requiring clinics to register with the state, follow informed consent protocols, and avoid deceptive advertising.
Will I still be able to get regenerative therapies in Florida if the bill passes?
Yes. Patients will still have access to regenerative therapies, but clinics must comply with new standards. This makes it easier for patients to identify legitimate providers like STEMS Health and avoid risky or misleading alternatives.
What makes STEMS Health different under this new law?
STEMS Health already operates with the safety standards, transparency, and ethical practices that HB 1617 mandates. That means no disruption to your care—just greater assurance that you’re in capable, compliant hands.
STEMS Health already operates with the safety standards, transparency, and ethical practices that HB 1617 mandates. That means no disruption to your care—just greater assurance that you’re in capable, compliant hands.
